Related Experiment Video
Updated: Jun 22, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Systemic lupus erythematosus clinical trials-an interim analysis
1Division of Rheumatology, University of California, San Francisco, CA 94121, USA.
Nature Reviews. Rheumatology
|June 4, 2009
Summary
No new drugs for systemic lupus erythematosus (SLE) have been approved in 50 years. This review analyzes recent clinical trials, seeking insights to guide future SLE treatment development.
Area of Science:
- Rheumatology
- Immunology
- Clinical Pharmacology
Background:
- Systemic lupus erythematosus (SLE) lacks approved therapies despite recent interest in drug development.
- Biologic therapies have shown success in other autoimmune diseases, spurring SLE research.
- Despite numerous clinical trials, effective SLE treatments remain elusive.
Purpose of the Study:
- To analyze major clinical trials for systemic lupus erythematosus (SLE) treatments.
- To interpret trial results to identify pathways for future drug discovery.
- To address the stagnation in SLE therapeutic development.
Main Methods:
- Review and analysis of published SLE clinical trial data.
- Interpretation of efficacy and safety outcomes from recent trials.
- Synthesis of findings to guide future research directions.
Main Results:
- Significant clinical trial activity has not yet yielded an approved SLE therapy.
- Analysis reveals challenges and potential reasons for treatment failures.
- Biologic therapies show promise but require further refinement for SLE.
Conclusions:
- The path to effective SLE treatment requires a deeper understanding of trial outcomes.
- Future drug development should leverage insights from past clinical trial analyses.
- Overcoming the historical lack of approved SLE treatments necessitates strategic re-evaluation.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...